circRNA basic information
circBase ID: hsa_circ_0028861
Name: -
Synonym: -
Host Gene: -
Genomic location(hg19): chr12:120636656-120636803:-
Genomic location(hg38): chr12:120198853-120199000:-
Subcellular localization: not tested
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0007256
MONDO name: hepatocellular carcinoma
Disease details: hepatocellular carcinoma
Disease DO ID:
684, 686
Disease MeSH ID:
D006528
Disease NCIt ID:
C3099
Disease ICD11 ID:
1294035808
Disease OMIM ID:
114550
Species: Human
Species details: Homo sapiens
Tissue specimen:

tumor tissues; adjacent tissues

Cell lines:

WRL68; HepG2; Huh7

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
UP
Associated gene: -
Associated microRNA: -
Biological function: hsa_circ_0028861 promotes HCC cell proliferation, migration, EMT, and tumor growth; curcumol inhibits HCC progression by downregulating hsa_circ_0028861.
Molecular mechanism: Curcumol downregulates hsa_circ_0028861 expression and mediates the EMT process; the precise molecular mechanism of hsa_circ_0028861 remains unclear.
Biological pathway or process:

proliferation (promotes); migration (promotes); EMT (promotes)

Detected method:
Q
Validation methods:

RT-qPCR; Clinical Sample Validation; Transfection; CCK8; EdU Staining; Wound Healing Assay; Transwell Assay; Western Blot; In Vivo Animal Model

Clinical significance:

hsa_circ_0028861 could serve as a novel therapeutic target for HCC treatment.

Description:

This study found that hsa_circ_0028861 is up-regulated in HCC tumor tissues and HCC cell lines. Overexpression of hsa_circ_0028861 promotes proliferation, migration, EMT, and tumor growth, while curcumol suppresses these malignant phenotypes by downregulating hsa_circ_0028861. The circRNA is proposed as a potential therapeutic target for HCC.

Confidence score:

0.5442

Other information
Title:

Curcumol Inhibits the Progression of Hepatocellular Carcinoma by Regulating the Expression of hsa_circ_0028861.

Journal: Cancer biotherapy & radiopharmaceuticals
Published: 2024
PubMed ID: 38181186
Study type:

combined biological and clinical study

Data availability: The data that supported the findings of this study are available upon reasonable request from the corresponding author.
Code availability: -